U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C15H20N2O
Molecular Weight 244.3321
Optical Activity ( + )
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 5-MEO-MPMI

SMILES

COC1=CC2=C(NC=C2C[C@H]3CCCN3C)C=C1

InChI

InChIKey=MKEGUJPBCIXABO-GFCCVEGCSA-N
InChI=1S/C15H20N2O/c1-17-7-3-4-12(17)8-11-10-16-15-6-5-13(18-2)9-14(11)15/h5-6,9-10,12,16H,3-4,7-8H2,1-2H3/t12-/m1/s1

HIDE SMILES / InChI

Molecular Formula C15H20N2O
Molecular Weight 244.3321
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 10:15:16 UTC 2023
Edited
by admin
on Sat Dec 16 10:15:16 UTC 2023
Record UNII
N29TFW7VRV
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
5-MEO-MPMI
Common Name English
(R)-3-(N-METHYLPYRROLIDIN-2-YLMETHYL)-5-METHOXYINDOLE
Common Name English
1H-INDOLE, 5-METHOXY-3-(((2R)-1-METHYL-2-PYRROLIDINYL)METHYL)-
Systematic Name English
5-METHOXY-N-METHYL-(.ALPHA.,N-TRIMETHYLENE)TRYPTAMINE
Common Name English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-5-MeO-MPMI
Created by admin on Sat Dec 16 10:15:16 UTC 2023 , Edited by admin on Sat Dec 16 10:15:16 UTC 2023
Code System Code Type Description
WIKIPEDIA
5-MEO-MPMI
Created by admin on Sat Dec 16 10:15:16 UTC 2023 , Edited by admin on Sat Dec 16 10:15:16 UTC 2023
PRIMARY 5-MeO-MPMI (also known as 5-Methoxy-N-methyl-(α,N-trimethylene)tryptamine) is a tryptamine derivative that is a psychedelic drug. It was first developed by the team led by JE Macor in 1992,[1] and subsequently investigated by the team led by David Nichols from Purdue University in the late 1990s. This compound produces psychedelic-appropriate responding in animal tests with a similar potency to the amphetamine-derived psychedelic DOI, and has two enantiomers, with only the (R)-enantiomer being active.
CAS
143321-57-7
Created by admin on Sat Dec 16 10:15:16 UTC 2023 , Edited by admin on Sat Dec 16 10:15:16 UTC 2023
PRIMARY
PUBCHEM
9881324
Created by admin on Sat Dec 16 10:15:16 UTC 2023 , Edited by admin on Sat Dec 16 10:15:16 UTC 2023
PRIMARY
FDA UNII
N29TFW7VRV
Created by admin on Sat Dec 16 10:15:16 UTC 2023 , Edited by admin on Sat Dec 16 10:15:16 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> AGONIST
Ki
Related Record Type Details
ACTIVE MOIETY